Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.65
+0.03 (0.22%)
At close: Aug 11, 2026, 4:00 PM EDT
13.65
0.00 (0.00%)
Pre-market: Aug 12, 2026, 7:38 AM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $3.58 billion as of August 12, 2026. Its market cap has increased by 49.55% in one year.
Market Cap
3.58B
Enterprise Value
11.01B
1-Year Change
49.55%
Ranking
Category
Stock Price
$13.65
ChartMarket Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $3.58B, a decrease of -57.41%. That is a compound annual growth rate of -15.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 3.58B | 92.30% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 251.46B |
| Amgen | 225.55B |
| Novo Nordisk | 209.18B |
| Gilead Sciences | 164.99B |
| Pfizer | 154.18B |
| Bristol-Myers Squibb Company | 132.45B |
| Sanofi | 104.53B |
| GSK plc | 104.44B |